I’m not aware of any data outside of the preclinical data they referred to for efti in infectious disease. With infectious disease patents in Japan and Europe, I guess it’s only because of resources efti has not been tried in infectious disease. The hypothesis for Covid-19 is worth trying, especially with all the noodles being thrown at the wall by other companies.. AMRN is trying fish oil for the cardiovascular effects of Covid-19. Come on, let’s see is APC activation shortens infection, like soon.
I’m not aware of any data outside of the preclinical data they...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
0.005(1.61%) |
Mkt cap ! $458.1M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.5¢ | 30.5¢ | $251.5K | 806.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 121215 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 2864 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |